Dec 16 WATCH: Moderna COVID-19 vaccine set for approval in U.S. with panel endorsement By Matthew Perrone, Lauran Neergaard, Associated Press The FDA reviewers said that the two-dose vaccine “was highly effective” in preventing symptomatic COVID-19 from occurring “at least 14 days after the receipt of the second dose.”… Continue reading
Dec 15 FDA approves first over-the-counter home test for COVID-19 By Matthew Perrone, Associated Press The test kit from an Australian company allows users to swab themselves and get the results at home in about 20 minutes. Continue reading
Dec 12 US says COVID-19 vaccine to start arriving in states Monday By Lauran Neergaard, Jonathan Lemire and Catherine Lucey, Matthew Perrone, Associated Press The nation’s first COVID-19 vaccine will begin arriving in states Monday morning, U.S. officials said Saturday, after the government gave the final go-ahead to the shots needed to end an outbreak that has killed nearly 300,000 Americans. Continue reading
Dec 08 WATCH: FDA advisers endorse Pfizer COVID-19 vaccine for emergency authorization By Lauran Neergaard, Matthew Perrone, Associated Press A U.S. government advisory panel has endorsed Pfizer's coronavirus vaccine, in a major step toward an epic vaccination campaign that could finally conquer the outbreak. Continue reading
Dec 08 U.S. is taking final steps to review the first COVID-19 vaccine. Here’s what’s next By Associated Press The Food and Drug Administration posted a positive review of the Pfizer vaccine on Tuesday and will hold a public hearing on Thursday. The Associated Press has a look at the process. Continue reading
Dec 06 Watch 5:27 A whistleblower says the FDA isn’t properly regulating vaccine facilities While much attention has been given to approving a COVID-19 vaccine, there's been little paid to the facilities where many vaccines are manufactured. A recent investigation in Vanity Fair features a former FDA inspector turned whistleblower who says that the… Continue watching
Nov 30 Risk of COVID-19 scams as vaccine approaches FDA approval By Colleen Long, Associated Press The coronavirus vaccine inching toward approval in the U.S. is desperately anticipated by Americans longing for a path back to normal life. But criminals are waiting, too. They're ready to use that desperation to their advantage. Continue reading
Oct 23 AstraZeneca, Johnson & Johnson resume U.S. tests of COVID-19 vaccines By Linda A. Johnson, Associated Press Two drugmakers say they have the go-ahead to resuming U.S. testing of their COVID-19 vaccine candidates. Both are in the final stage of testing before the companies can seek regulatory approval. Continue reading
Oct 22 U.S. regulators, experts take up thorny vaccine study issues By Lauran Neergaard, Matthew Perrone, Associated Press With vaccines against COVID-19 inching closer, U.S. regulators took an unusual step Thursday in asking outside scientists: Are the government's standards high enough to adequately judge the shots?… Continue reading
Oct 22 WATCH: FDA advisory committee assesses COVID-19 vaccine development By Helen Branswell, STAT This week's meeting, while likely dry and technical, "shows the public that this is how FDA is going about its decisions," one expert said. Continue reading